Detection of Epstein-Barr Viral RNA in Malignant Lymphomas of the Upper Aerodigestive Tract
Overview
Affiliations
Recent studies have suggested a probable etiologic association between Epstein-Barr virus (EBV) and nasal lymphomas, irrespective of geographic location. This study was performed to investigate the strength of association of EBV with non-Hodgkin's lymphomas of the upper aerodigestive tract, based on a large series of cases that have been thoroughly immunophenotyped on frozen tissues. A sensitive in situ hybridization technique was used to detect EBV encoded RNA (EBER) in paraffin sections. Among 30 cases of nasal/nasopharyngeal T-cell lymphoma, 25 (83.3%) were EBER-positive. In the positive cases, most of the neoplastic cells showed strong nuclear signals. Further analysis of this group of tumors showed that all 21 cases (100%) with a CD56+ CD3-phenotype were EBER positive, whereas four of nine cases (44.4%) with a CD56-negative immunophenotype were positive. Only one of 10 cases (10%) of nasal/nasopharyngeal B-cell lymphoma was EBER positive; the positive case was a diffuse mixed-cell lymphoma and could not be distinguished morphologically from the negative cases. Among the 21 cases of lymphoma of the tonsils and back of the tongue (20 B-lineage and one T-lineage), none was EBER positive. In the normal mucosa of the nose/nasopharynx or tonsil (20 cases studied), only very rare EBER-positive small lymphocytes were found in two cases. The almost exclusive detection of EBER in nasal/nasopharyngeal T-cell neoplasms among the lymphomas of the upper aerodigestive tract suggests that EBV probably plays an etiologic role in the pathogenesis of this group of tumors and is not simply a passenger virus, and neither is this merely a site-dependent phenomenon in view of the weak association with nasal/nasopharyngeal B-cell lymphoma.
Lee J, Yoon S, Kim S, Kim W, Cho J Ann Hematol. 2024; 103(12):5749-5757.
PMID: 39589496 DOI: 10.1007/s00277-024-06035-w.
Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.
Li D, Lun L Front Med (Lausanne). 2022; 9:851208.
PMID: 35783622 PMC: 9248758. DOI: 10.3389/fmed.2022.851208.
Liu W, Chen Z, Li F, Zhang W, Liu W, Zhao S Orphanet J Rare Dis. 2021; 16(1):479.
PMID: 34794461 PMC: 8600691. DOI: 10.1186/s13023-021-02110-x.
Tvedten E, Richardson J, Motaparthi K Cureus. 2021; 13(9):e17987.
PMID: 34540511 PMC: 8445857. DOI: 10.7759/cureus.17987.
Updating targets for natural killer/T-cell lymphoma immunotherapy.
Xue W, Zhang M Cancer Biol Med. 2021; 18(1):52-62.
PMID: 33628584 PMC: 7877170. DOI: 10.20892/j.issn.2095-3941.2020.0400.